Lung & Respiratory Disease Clinical Trials Update: Week 33, 2026

Published August 14, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.

A Study to Evaluate the Efficacy and Safety of QVM149 Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma

This Phase 3 study is testing a new inhaler treatment called QVM149, which combines three medicines, in children aged 12 to under 18 who have asthma. The goal is to find out if this new treatment works better and is as safe as the current standard inhaler. If successful, it could offer young people with moderate asthma a new option to help control their symptoms more effectively.

Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)

This Phase 2 trial is exploring a new approach for adults who have recurrent respiratory papillomatosis, a condition where growths called papillomas repeatedly form in the airway and cause trouble breathing or speaking. The study combines a vaccine called PRGN-2012 with a drug called bevacizumab to see if this treatment can reduce how often these growths come back. This could provide a new way to manage a difficult condition that often requires multiple surgeries.

MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)

This trial tested a stem cell therapy named MultiStem for adults suffering from severe lung failure caused by COVID-19. The therapy aims to improve lung recovery and reduce complications in patients with acute respiratory distress syndrome (ARDS). Although the study ended early and results are still pending, it represents ongoing efforts to find better treatments for severe COVID-19 lung problems.

The Barts Charity Children's Environmental Health Clinic

This study is focused on children with chronic respiratory conditions like asthma and looks at how monitoring and reducing harmful environmental exposures at home can improve their health. By personalizing interventions based on each child’s living environment, the trial hopes to lower asthma attacks and other respiratory problems. This approach could help many children breathe easier by addressing the triggers in their daily surroundings.

Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients

This trial investigates ways to support breathing in severely obese patients after they have had a breathing tube removed. The goal is to prevent the need to put the tube back in, which can lead to serious health issues. Noninvasive methods being studied could make recovery safer and smoother for this vulnerable group of patients.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.